SoP Changes Effective 21 June 2021

[nicholasamiller]

SoPs for the following conditions become effective on legally and in SoP API on 21 June 2021:

• gastro-oesophageal reflux disease
• malignant neoplasm of the oral cavity, oropharynx and hypopharynx
• asbestosis
• pes planus
• porphyria cutanea tarda

These SoPs repeal and replace SoPs for conditions with the same name.

SoPs for IgA nephropathy become effective on the same date. These replace the SoPs for mesangial IgA glomerulonephritis. (The impact is that, from 21 June 2021, veterans should no longer be able to apply for initial liability for mesangial IgA glomerulonephritis, but they should be able to apply for IgA nephropathy.)

SoPs for the following new conditions also become effective at the same time:

• transverse myelitis
• hypogonadism

The SoPs for non-Hodgkin lymphoma were amended effective 21 June; the Federal Register published updated compilations on 22 June; these were deployed to SoP API on 23 June.